China SXT Pharmaceuticals, Inc. (SXTC)

NASDAQ: SXTC · IEX Real-Time Price · USD
0.187
-0.005 (-2.71%)
At close: Jan 21, 2022 4:00 PM
0.195
0.008 (4.234%)
After-hours:Jan 21, 2022 7:59 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Apr - Mar.
Year20202019201820172016
Revenue
0.880.330.211.320.73
Revenue Growth (YoY)
167.83%55.75%-83.89%80.04%-
Cost of Revenue
-1.94-2.46-2.4-3.62-2.57
Gross Profit
2.822.792.614.933.3
Selling, General & Admin
5.044.042.841.770.71
Operating Expenses
5.044.042.841.770.71
Operating Income
-2.21-1.26-0.233.172.59
Interest Expense / Income
1.623.350.0100.04
Other Expense / Income
-0.895.78-2.031.540.97
Pretax Income
-2.94-10.391.791.631.58
Income Tax
-0.19-0.10.250.440.4
Net Income
-2.75-10.291.541.191.19
Net Income Common
-2.75-10.291.541.191.19
Net Income Growth
--29.61%0.21%-
Shares Outstanding (Basic)
146555
Shares Outstanding (Diluted)
146555
Shares Change
132.78%20.23%2.84%0.00%-
EPS (Basic)
-0.19-1.660.300.240.24
EPS (Diluted)
-0.19-1.660.300.240.24
EPS Growth
--26.69%0.00%-
Free Cash Flow Per Share
-0.100.09-0.070.180.02
Gross Margin
318.99%844.05%1231.48%374.69%451.26%
Operating Margin
-250.13%-380.06%-108.13%240.35%354.23%
Profit Margin
-310.53%-3113.48%725.52%90.17%162.01%
Free Cash Flow Margin
-159.28%159.67%-169.51%67.61%15.57%
Effective Tax Rate
6.55%0.98%14.08%27.04%25.00%
EBITDA
-0.98-6.711.981.761.72
EBITDA Margin
-110.74%-2030.37%932.13%133.47%235.11%
EBIT
-1.33-7.041.81.631.62
EBIT Margin
-149.77%-2130.80%846.85%123.65%221.54%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).